Axillary Lymphadenopathy on Ultrasound after COVID-19 Vaccination and Its Influencing Factors: A Single-Center Study.
Ji Yeon ParkJi Young LeeSeong Yoon YiPublished in: Journal of clinical medicine (2022)
COVID-19 vaccine-related axillary lymphadenopathy on ultrasound is common. mRNA type, an interval of 4 weeks, younger age, and first dose were the important factors. Breast clinicians should be well aware of these side effects when performing imaging examinations and provide accurate information to patients.
Keyphrases
- coronavirus disease
- sars cov
- ultrasound guided
- end stage renal disease
- lymph node
- magnetic resonance imaging
- high resolution
- neoadjuvant chemotherapy
- newly diagnosed
- fine needle aspiration
- chronic kidney disease
- ejection fraction
- peritoneal dialysis
- palliative care
- squamous cell carcinoma
- early stage
- radiation therapy
- contrast enhanced ultrasound
- binding protein
- patient reported outcomes
- locally advanced
- gestational age
- patient reported
- drug induced